PGD for fragile X syndrome: ovarian function is the main determinant of success | Zendy

Avi Tsafrir | Zendy; Gheona Altarescu | Zendy; Ehud J. Margalioth | Zendy; B. Brooks | Zendy; Paul Renbaum | Zendy; Ephrat LevyLahad | Zendy; Ron Rabinowitz | Zendy; Irit Varshaver | Zendy; Talia EldarGeva | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

PGD for fragile X syndrome: ovarian function is the main determinant of success

Author(s) -

Avi Tsafrir,

Gheona Altarescu,

Ehud J. Margalioth,

B. Brooks,

Paul Renbaum,

Ephrat LevyLahad,

Ron Rabinowitz,

Irit Varshaver,

Talia EldarGeva

Publication year - 2010

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/deq203

Subject(s) - medicine , embryo transfer , frax , gynecology , fragile x syndrome , pregnancy rate , obstetrics , pregnancy , fragile x , andrology , biology , genetics , gene , bone mineral , osteoporosis , osteoporotic fracture , psychiatry

PGD for fragile X syndrome (FRAX) is inefficient, probably owing to fewer oocytes, poor embryo quality and difficulties in genetic analysis. We investigated IVF-PGD in FRAX mutation carriers compared with controls, looking at the effects of oocyte and embryo number/quality on live birth outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research